YIKILMAZ, T. N.; DIRIM, A.; AYVA, E. S.; OZDEMIR, H.; OZKARDES, H. Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin. Urology Journal, [S. l.], v. 13, n. 3, p. 2677–2683, 2016. DOI: 10.22037/uj.v13i3.3294. Disponível em: https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/3294. Acesso em: 2 may. 2024.